Practices


Vioxx Lawsuits may be difficult to Prove

October 10, 2004 - Evelyn Irvin Plunkett said she remembers the day her husband starting taking Vioxx for back pain. It was April 15, 2001. Read More


FDA accused of silencing Vioxx Warnings

October 8, 2004 - The FDA silenced one of its drug experts who raised safety concerns weeks before Merck & Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes. Read More


Merck braces for wave of Vioxx Lawsuits

October 3, 2004 - The flood of phone calls to plaintiffs' lawyers began soon after pharmaceutical giant Merck & Co. announced that it would withdraw its painkiller Vioxx from the market because of safety... Read More


Merck braces for another Deluge of Lawsuits by Vioxx Users

October 3, 2004 - Following Merck & Co.'s withdrawal of the blockbuster painkiller Vioxx, patients, shareholders and even the company began scrambling to figure out their next moves. Read More


Merck to face Billions in Lawsuits

October 2, 2004 - Merck could face legal liabilities of up to $10B following its worldwide withdrawal of the blockbuster pain drug Vioxx, according to some analysts' estimates. Read More


A Blow to Efforts to Close in on Rivals

October 1, 2004 - Merck & Company's decision to stop selling the painkiller Vioxx, one of its most profitable drugs, could hardly have come at a worse time for the company. Read More


Merck estimates $2.5B impact from pulling Vioxx

October 1, 2004 - Merck ended the life of a pain-relief drug that was part of the most successful product launch in history when it hit the market in 1999. Read More


News on Vioxx: A Shot in the Arm for Plaintiffs Bar

October 1, 2004 - The plaintiffs bar was heartened when pharmaceutical giant Merck & Co. stopped sales of Vioxx, a popular arthritis drug that relieves aches and pains, but increases the risk of heart... Read More


Merck recalls Vioxx

September 30, 2004 - A new FDA study found patients taking a high dose of Vioxx were three times more likely to have a heart attack. As a result, Merck & Co. is pulling the arthritis drug from the market. Read More


Recall of Vioxx after Study Shows New Risk

September 30, 2004 - Merck and Co. said it was voluntarily withdrawing its arthritis and pain medication Vioxx effective immediately after a study revealed an increased relative risk for cardiovascular problems. Read More


back to top